8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 8, 2024 · 2y ago · Accession 0001193125-24-003968
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- 8-K
- Filing date
- Jan 8, 2024
- Report date
- Jan 8, 2024
- Document
- d104627d8k.htm
- Size
- 10.2 MB